Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac440Source: DataRank Database

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis is a research paper published in Open Forum Infectious Diseases (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Stalz Charles Vilbrun ORCID,Ariadne Souroutzidis,Joshua Ellis ORCID,Sobiesyke Delva,Guy Joissaint

Live enrichment

PubMed:36172057 PMC:PMC9512704 OpenAlex:https://openalex.org/W4293662909

National Institutes of Health

Grant: K23-AI131913

NIAID NIH HHS

Grant: K23 AI131913

NIAID NIH HHS

Grant: U19 AI162568

National Institutes of Health

Grant: 1K23AI131913-01A1

Host susceptibility to Mycobacterium tuberculosis recurrence in HIV-infected people

Weill Cornell Medicine

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1093/ofid/ofac440

publisherhttps://doi.org/10.1093/ofid/ofac440

publisherhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofac440/45601678/ofac440.pdf

publisherhttps://academic.oup.com/ofid/article-pdf/9/9/ofac440/46053003/ofac440.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36172057

Fields of Study

Tuberculosis Research and EpidemiologyHIV/AIDS drug development and treatmentPharmacological Effects and Toxicity Studies0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

BedaquilineMedicineIsoniazidCulture conversionTuberculosisDrugInternal medicinePharmacologyMycobacterium tuberculosisPulmonary tuberculosisPathologyTreatment OutcomesDrug-resistant TuberculosisHigh-dose IsoniazidTime To Culture ConversionBrief Report

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis

FAIR Checklist

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)